Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T and risk of myocardial infarction: A meta-analysis for 8,140 cases and 10,522 controls

Archives of Medical Research

Volumn 42, Issue 8, 2011, Pages 677-685

  Xuan, Chao ^a   Bai, Xiao Yan ^a   Gao, Ge ^a   Yang, Qin ^a,b   He, Guo Wei ^a,c  

^a NANKAI UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Meta analysis; MTHFR; Myocardial infarction; Polymorphism

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

AFRICAN AMERICAN; ARTICLE; ASIAN; BIOSIS; CASE CONTROL STUDY; CAUCASIAN; COCHRANE LIBRARY; EAST ASIAN; ETHNIC DIFFERENCE; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HEART INFARCTION; HUMAN; MEDLINE; META ANALYSIS (TOPIC); MIDDLE AGED; PUBLISHING; SEX RATIO; SOUTH ASIAN;

CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84856900237     PISSN: 01884409     EISSN: 18735487     Source Type: Journal    
DOI: 10.1016/j.arcmed.2011.11.009     Document Type: Article

References (61)

1. Manson J.E., Tosteson H., Ridker P.M., et al. The primary prevention of myocardial infarction. N Engl J Med 1992, 326:1406-1416.
2. Bing R.J. Myocardial ischemia and infarction: growth of ideas. Cardiovasc Res 2001, 51:13-20.
3. Bowron A., Scott J., Stansbie D. The influence of genetic and environmental factors on plasma homocysteine concentrations in a population at high risk for coronary artery disease. Ann Clin Biochem 2005, 42:459-462.
4. Tyroler H.A., Haynes S.G., Cobb L.A., et al. Environmental risk factors in coronary artery disease. Circulation 1987, 76:I139-I144.
5. Cipriani V., Mannucci P.M., Ardissino D., et al. Familial aggregation of early-onset myocardial infarction. Eur J Intern Med 2010, 21:511-515.
6. Brown D.W., Giles W.H., Burke W., et al. Familial aggregation of early-onset myocardial infarction. Community Genet 2002, 5:232-238.
7. Weiss N., Keller C., Hoffmann U., et al. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med 2002, 7:227-239.
8. Sadeghian S., Fallahi F., Salarifar M., et al. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord 2006, 6:38.
9. von Eckardstein A., Assmann G. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997, 337:1632-1633.
10. Rogers E.J., Chen S., Chan A. Folate deficiency and plasma homocysteine during increased oxidative stress. N Engl J Med 2007, 357:421-422.
11. Tsuda K., Nishio I. Serum homocysteine and endothelial dysfunction in circulatory disorders in women. Circulation 2004, 110:e37.
12. Biselli P.M., Guerzoni A.R., de Godoy M.F., et al. Genetic polymorphisms involved in folate metabolism and concentrations of methylmalonic acid and folate on plasma homocysteine and risk of coronary artery disease. J Thromb Thrombolysis 2010, 29:32-40.
13. Nygard O., Vollset S.E., Refsum H., et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995, 274:1526-1533.
14. Brattstrom L., Wilcken D.E., Ohrvik J., et al. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation 1998, 98:2520-2526.
15. Frosst P., Blom H.J., Milos R., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995, 10:111-113.
16. Schwartz S.M., Siscovick D.S., Malinow M.R., et al. Myocardial infarction in young women in relation to plasma total homocysteine, folate, and a common variant in the methylenetetrahydrofolate reductase gene. Circulation 1997, 96:412-417.
17. Kerkeni M., Addad F., Chauffert M., et al. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease. Ann Clin Biochem 2006, 43:200-206.
18. Doshi S.N., McDowell I.F., Moat S.J., et al. Folate improves endothelial function in coronary artery disease: an effect mediated by reduction of intracellular superoxide?. Arterioscler Thromb Vasc Biol 2001, 21:1196-1202.
19. Brugada R., Marian A.J. A common mutation in methylenetetrahydrofolate reductase gene is not a major risk of coronary artery disease or myocardial infarction. Atherosclerosis 1997, 128:107-112.
20. Shioji K., Kokubo Y., Goto Y., et al. An association analysis between genetic polymorphisms of matrix metalloproteinase-3 and methylenetetrahydrofolate reductase and myocardial infarction in Japanese. J Thromb Haemost 2004, 2:527-528.
21. Yamada Y., Matsuo H., Segawa T., et al. Assessment of genetic risk for myocardial infarction. Thromb Haemost 2006, 96:220-227.
22. Thakkinstian A., McEvoy M., Minelli C., et al. Systematic review and meta-analysis of the association between β2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol 2005, 162:201-211.
23. Bowden J., Tierney J.F., Copas A.J., et al. Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics. BMC Med Res Methodol 2011, 11:41.
24. Higgins J.P., Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558.
25. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
26. Adams M., Smith P.D., Martin D., et al. Genetic analysis of thermolabile methylenetetrahydrofolate reductase as a risk factor for myocardial infarction. QJM 1996, 89:437-444.
27. Schmitz C., Lindpaintner K., Verhoef P., et al. Genetic polymorphism of methylenetetrahydrofolate reductase and myocardial infarction. A case-control study. Circulation 1996, 94:1812-1814.
28. Ma J., Stampfer M.J., Hennekens C.H., et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996, 94:2410-2416.
29. Anderson J.L., King G.J., Thomson M.J., et al. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increased risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 1997, 30:1206-1211.
30. Girelli D., Friso S., Trabetti E., et al. Methylenetetrahydrofolate reductase C677T mutation, plasma homocysteine, and folate in subjects from northern Italy with or without angiographically documented severe coronary atherosclerotic disease: evidence for an important genetic-environmental interaction. Blood 1998, 91:4158-4163.
31. Abbate R., Sardi I., Pepe G., et al. The high prevalence of thermolabile 5-10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD). Thromb Haemost 1998, 79:727-730.
32. Ferrer-Antunes C., Palmeiro A., Morais J., et al. The mutation C677T in the methylene tetrahydrofolate reductase gene as a risk factor for myocardial infarction in the Portuguese population. Thromb Haemost 1998, 80:521-522.
33. Anderson J.L., King G.J., Thomson M.J., et al. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999, 94:46-51.
34. Gardemann A., Weidemann H., Philipp M., et al. The TT genotype of the methylenetetrahydrofolate reductase C677T gene polymorphism is associated with the extent of coronary atherosclerosis in patients at high risk for coronary artery disease. Eur Heart J 1999, 20:584-592.
35. Fernandez-Arcas N., Dieguez-Lucena J.L., Munoz-Moran E., et al. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction. Atherosclerosis 1999, 145:293-300.
36. Thogersen A.M., Nilsson T.K., Dahlen G., et al. Homozygosity for the C677→T mutation of 5,10-methylenetetrahydrofolate reductase and total plasma homocyst(e) ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden. Coron Artery Dis 2001, 12:85-90.
37. Virgos C., Joven J., Simo J.M., et al. Homocyst(e)ine and the C677T mutation of methylenetetrahydrofolate reductase in survivors of premature myocardial infarction. Clin Biochem 2000, 33:509-512.
38. Gulec S., Aras O., Akar E., et al. Methylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 2001, 24:281-284.
39. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 2003, 107:1117-1122. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group.
40. Tanis B.C., Blom H.J., Bloemenkamp D.G., et al. Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C→T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels. J Thromb Haemost 2004, 2:35-41.
41. El-Sammak M., Kandil M., El-Hifni S., et al. Elevated plasma homocysteine is positively associated with age independent of C677T mutation of the methylenetetrahydrofolate reductase gene in selected Egyptian subjects. Int J Med Sci 2004, 1:181-192.
42. Salazar-Sanchez L., Chaves L., Cartin M., et al. Common polymorphisms and cardiovascular factors in patients with myocardial infarction of Costa Rica. Rev Biol Trop 2006, 54:1-11.
43. Helfenstein T., Fonseca F.A., Relvas W.G., et al. Prevalence of myocardial infarction is related to hyperhomocysteinemia but not influenced by C677T methylenetetrahydrofolate reductase and A2756G methionine synthase polymorphisms in diabetic and non-diabetic subjects. Clin Chim Acta 2005, 355:165-172.
44. Celik M., Altintas A., Celik Y., et al. Thrombophilia in young patients with acute myocardial infarction. Saudi Med J 2008, 29:48-54.
45. Nakai K., Fusazaki T., Suzuki T., et al. Genetic polymorphism of 5,10-methylenetetrahydrofolate increases risk of myocardial infarction and is correlated to elevated levels of homocysteine in the Japanese general population. Coron Artery Dis 2000, 11:47-51.
46. Zhang G., Dai C. Gene polymorphisms of homocysteine metabolism-related enzymes in Chinese patients with occlusive coronary artery or cerebral vascular diseases. Thromb Res 2001, 104:187-195.
47. Ranjith N., Pegoraro R.J., Rom L. Risk factors and methylenetetrahydrofolate reductase gene polymorphisms in a young South African Indian-based population with acute myocardial infarction. Cardiovasc J S Afr 2003, 14:127-132.
48. Angeline T., Jeyaraj N., Granito S., et al. Prevalence of MTHFR gene polymorphisms (C677T and A1298C) among Tamilians. Exp Mol Pathol 2004, 77:85-88.
49. Iqbal M.P., Fatima T., Parveen S., et al. Lack of association of methylenetetrahydrofolate reductase 677C>T mutation with coronary artery disease in a Pakistani population. J Mol Genet Med 2005, 1:26-32.
50. Dayakar S., Goud K.I., Reddy T.P., et al. Sequence variation of the methylene tetrahydrofolate reductase gene (677C>T and 1298 A>C) and traditional risk factors in a South Indian Population. Genet Test Mol Biomarkers 2011, [Epub ahead of print].
51. Dilley A., Hooper W.C., El-Jamil M., et al. Mutations in the genes regulating methylene tetrahydrofolate reductase (MTHFR C→T677) and cystathione beta-synthase (CBS G→A919, CBS T→C833) are not associated with myocardial infarction in African Americans. Thromb Res 2001, 103:109-115.
52. Lloyd-Jones D., Adams R.J., Brown T.M., et al. Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 2010, 121:e46-e215.
53. Yamada Y., Ichihara S., Nishida T. Molecular genetics of myocardial infarction. Genomic Med 2008, 2:7-22.
54. Kelly M., Semsarian C. Multiple mutations in genetic cardiovascular disease: a marker of disease severity?. Circ Cardiovasc Genet 2009, 2:182-190.
55. Luepker R.V. Careers in cardiovascular disease epidemiology and prevention. Circulation 2009, 120:533-538.
56. Milani R.V., Lavie C.J. Homocysteine: the Rubik's cube of cardiovascular risk factors. Mayo Clin Proc 2008, 83:1200-1202.
57. Lohmueller K.E., Pearce C.L., Pike M., et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003, 33:177-182.
58. Kluijtmans L.A., Kastelein J.J., Lindemans J., et al. Thermolabile methylenetetrahydrofolate reductase in coronary artery disease. Circulation 1997, 96:2573-2577.
59. Jee S.H., Beaty T.H., Suh I., et al. The methylenetetrahydrofolate reductasegene is associated with increased cardiovascular risk in Japan, but not in other populations. Atherosclerosis 2000, 153:161-168.
60. Kim R.J., Becker R.C. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 2003, 146:948-957.
61. Lewis S.J., Ebrahim S., Davey Smith G. Meta-analysis of MTHFR 677C→T polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?. BMJ 2005, 331:1053.